Oracle of Organon: Buffett’s Berkshire cashes out on Biogen, trims pharma holdings but discloses stake in Merck spinoff
Oracle of Organon: Buffett’s Berkshire cashes out on Biogen, trims [...]
Oracle of Organon: Buffett’s Berkshire cashes out on Biogen, trims [...]
Recro Pharma takes manufacturing business ‘bi-coastal’ with $50M deal for [...]
FibroGen’s longtime CFO hands baton to J&J veteran as high-profile [...]
Merck’s Welireg scores FDA nod in cancers spurred by rare [...]
Ogilvy Health’s new PR practice chief talks pharma image and [...]
Organon shares jump as Merck’s new women’s health spinoff posts [...]
Fierce Pharma Asia—Seagen’s $2.6B bet on China biotech; Enhertu’s win [...]
Perfect packaging? J&J’s latest innovation challenge crowdsources single dose ideas [...]
Teva, Glenmark accuse U.S. government of improperly expanding price-fixing case [...]
Novartis, Pfizer and Gilead roll out COVID-19 vaccination rules as [...]